Family Stranded in Cold Under ‘Live Stop’ Policy
The controversial Philadelphia Police Department ‘Live Stop’ policy makes headlines again as local resident and criminal justice activist, Reuben Jones, was left on the side of the road in the extreme cold with his two children after police impounded his car for an expired registration. It is against PPD policy to leave drivers and their passengers […]
$2.5 M Risperdal Verdict Upheld in Superior Court
The Pennsylvania Superior Court has upheld the 2015 $2.5 million Risperdal verdict for plaintiff Austin Pledger. Pledger’s case was the first Risperdal case to go to trial. Viewed as a huge win for plaintiffs, the decision bodes well for the future litigation of 6,500 plaintiffs whose suits against Janssen Pharmaceutical, a subsidiary of Johnson & […]
J&J Settles Days Before Risperdal Trial
After years of litigation and several court losses for harm caused by Risperdal, Johnson & Johnson’s legal team agreed to settle the suit of a young boy from Mississippi who claims he developed female-like breasts after taking the drug Risperdal. The plaintiff began taking Risperdal in 2004 after he was tentatively diagnosed with bipolar disorder. J&J […]
PA Supreme Court Will Hear Appeal of Risperdal Time-Bar
The PA Supreme Court has agreed to review a Superior Court decision which would dismiss thousands of Risperdal cases due to statute of limitations. The two cases on appeal, Saksek v. Janssen and Winter v. Janssen, were dismissed for failing to bring a claim with in the applicable two year statue of limitations. The Supreme Court’s decision would […]
Judge Urges Appeals Court to Uphold $70M Risperdal Verdict
Philadelphia Court of Common Pleas Judge Paula Patrick urges the Pennsylvania Superior Court to uphold the $70 Million jury verdict in A.Y. v. Janssen Pharmaceuticals. AY is one of many boys who developed gynecomastia after taking Janssen’s anti-psychotic medication Risperdal. This is the 5th trial for Risperdal, with over 6,000 awaiting trial in a consolidated […]
Sheller Attorneys 2018 Super Lawyers
Super Lawyers has again recognized the attorneys of Sheller P.C. in 2018. Founder Stephen A. Sheller has been selected by the organization for the fifteenth consecutive year. Attorney Jamie L. Sheller have been awarded the honor multiple years, including 2018. Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas across […]
Sheller Panelist on Penn Law’s Legal Response to Opioid Conference
Sheller PC’s founder, Stephen Sheller, joined other litigators, judges and state prosecutors at a conference to discuss the legal response to the opioid crisis. The forum was hosted by University of Pennsylvania Law School’s Center for Ethics and the Rule of Law (CERL). The panel in which Sheller participated, Corporate Responsibility and Civil Law Solutions, […]
Sheller Joins Phila. in Suit Against Opioid Manufacturers
Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold them accountable for the current opioid crisis. Five pharmaceutical companies are named in the suit: Allergan, Janssen (a subsidiary of Johnson & Johnson and manufacturer of Risperdal), Endo, Cephalon, and […]
Superior Court Allows Punitive Damages in Risperdal Mass Torts
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling prohibited punitive damages. Boys and young men who developed gynecomastia, female-like breasts, from taking the antipsychotic drug and whose cases had already […]
High Court Won’t Hear Sheller Dispute with FDA over Risperdal
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug Supreme Court won’t weigh in on whether law firm can sue FDA over drug labeling Circumstances in which third parties can sue over government actions remain unclear By Dana A. Elfin A Philadelphia-based law firm has hit the end of the road in its bid […]
